Mikart LLC

Atlanta, GA
Small Molecule (Oral Solid Dose — tablets, capsules, powders-in-bottle) Non-sterile Oral Liquids and Suspensions Potent Compounds Controlled Substances (CI–CV) Combination Products Extended Release Products Pediatric and Geriatric Formulations
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (4) ○ EMA GMP ○ MHRA GMP

Quick Facts: Mikart LLC

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Atlanta, GA
Modalities
Small Molecule (Oral Solid Dose — tablets, capsules, powders-in-bottle), Non-sterile Oral Liquids and Suspensions, Potent Compounds, Controlled Substances (CI–CV), Combination Products, Extended Release Products, Pediatric and Geriatric Formulations
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Mikart LLC

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose — tablets, capsules, powders-in-bottle), Non-sterile Oral Liquids and Suspensions, Potent Compounds, Controlled Substances (CI–CV), Combination Products, Extended Release Products, Pediatric and Geriatric Formulations
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press4 articles
Broad modality coverage (7 modalities)

Recent News 4 articles

news Tue, 28 Ap
Mikart Celebrates Ribbon Cutting of New Atlanta Headquarters, Marking Major Milestone in Growth and Expansion - PR Newswire
Source →
news Tue, 22 Oc
Mikart Adds Nitrogen-Purged Liquid & Suspension Suites - Contract Pharma
Source →
news Tue, 11 Oc
Mikart, Nano PharmaSolutions Enter GMP Manufacturing Collaboration - Contract Pharma
Source →
news Thu, 18 Se
Mikart and Nano PharmaSolutions Announce Positive Interim Data from NT-301 Phase 1 Trial and Expansion of NanoTransformer® Manufacturing Capabilities - PR Newswire
Source →

Frequently Asked Questions About Mikart LLC

What is Mikart LLC's CDMO Signal Score?
Mikart LLC has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Mikart LLC for a manufacturing program?
Use the free AI matchmaker to compare Mikart LLC against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.